Search results
UK hit by outbreak of infection that causes ‘severe bloody diarrhoea’
Daily Express· 5 days agoHealth experts in the UK have issued an urgent warning amid an outbreak of a bacterial infection...
What drinking beer really does to your body – and the healthiest options for a pint
Daily Telegraph· 3 days agoBeer, and more precisely the alcohol in it, is paradoxically a sedative that disrupts sleep. It...
A lone star tick bite can cause a meat allergy: Here's what to watch out for this summer
USA Today· 3 days agoAlpha-gal syndrome is a serious and life-threatening allergic reaction that appears in mammals after...
Search for mystery 'nationally distributed food item' that spread E.coli to 113
Daily Express· 4 days agoAuthorities are on the hunt for a mystery “nationally distributed” food item they believe has...
What drinking beer really does to your body – and the healthiest options for a pint
The Telegraph via Yahoo News· 3 days agoA refreshing pint on a warm day is part of British culture. A pint after work on a Friday is, as TV...
Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates
Zacks via Yahoo Finance· 5 days agoThis study evaluated four different doses of VK2809 — 1 mg, 2.5 mg, 5 mg and 10mg. Results showed...
What’s Old May Be New Again: Addressing Radioactive Toxic Tort Claims and Planning for the Next...
JD Supra· 1 day agoEveryone in the world is exposed to some ionizing radiation every year. The effects of this exposure can vary substantially based on a number of...
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 3 days agoEli Lilly and Company (NYSE: LLY) announced detailed results from SYNERGY-NASH, a phase 2 study of 190 patients, with or without type 2 diabetes, to evaluate the investigational use of tirzepatide ...
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients...
Morningstar· 3 days agoEli Lilly and Company (NYSE: LLY) announced detailed results from SYNERGY-NASH, a phase 2 study of 190 patients, with or without type 2 diabetes, to evaluate the investigational use of tirzepatide ...
Stelara subcutaneous: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD
WebMD· 3 days agoBruising, itching, pain, redness, swelling, or hardening of the skin at the injection site may occur. Injection site reactions usually go away after 1 or 2 days. Remember that this medication ...
